CD105

CD105

a type II transmembrane protein present on endothelium, proerythryoblasts, activated monocytes and macrophages, and follicular dendritic cells that may play a role in adhesion; expressed in leukemic cells of B-lymphoid and myeloid origin.
References in periodicals archive ?
These cells expressed CD90, CD44, CD105, and CD73 but not CD45, CD11b, CD19, HLA-DR, and CD34 [Figure 2]b.
Third-passage DFSCs were incubated with the antibodies of positive markers for MSCs of human CD29 allophycocyanin (APC), CD73 phycoerythrin (PE), CD105 PE, and CD146 fluorescein isothiocyanate (FITC) and with the antibodies of negative markers of CD14 PE, CD34 FITC, CD45 APC, and HLA-DR PE (BD Biosciences, USA) for 15 min at room temperature in the dark.
PgLPS promoted cell proliferation, produced IL-1[beta] and TNF-[alpha], and did not affect the expression of stem cell markers, STRO-1, CD105 and OCT-4.
Elevated plasma CD105 and vitreous VEGF levels in diabetic retinopathy.
The criteria of the Mesenchymal and Tissue Stem Cell Committee of the International Society for Cellular Therapy reported that stem cells that expressing the markers of CD44, CD90, CD73 and CD105 are considered mesenchymal and those that express markers of CD19, CD14, CD34 or CD45 are regarded hematopoietic stem cells.
5] rat ADSCs were suspended in 50 [micro]L PBS with anti-human CD90 or anti-human CD105 conjugated with either phycoerythrin or fluorescein isothiocyanate (BD Biosciences, Franklin Lakes, NJ, U.
CD105, CD44, CD29, 9 (CD9), CD49f, CD90, major histocompatibility complex class I (MHC I), multipotent markers octamer-binding transcription factor 4 (Oct-4; the main regulator of differentiation in pluripotent cell line), stage-specific embryonic antigen 4 (SSEA-4; the marker used to differentiate between human and mouse cells and used to characterize pluripotent stem cells), and stromal-derived factor-1 (STRO1; used as identification, isolation, and functional testing of human bone marrow stromal progenitor cells) have been identified under fluorescent microscopy or by flow cytometry.
Voinea, "VEGF and CD105 immunoexpression in squamous cervical carcinomas and associated precancerous lesions," Romanian Journal of Morphology and Embryology, vol.
In addition, we also examined whether Dx modulated expression of CD molecules, such as CD105, CD137, and CD166, which are associated with atherosclerosis.